mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.09 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.09 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.058 |
0.1 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.1 |